je.st
news
Tag: 3
City Council Hearing: November 17, 2016 Staff Errata Memo #3
2016-11-18 21:42:04| PortlandOnline
PDF Document, 167kbCategory: Amendments and Errata
Tags: city
november
staff
council
Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection
2016-11-13 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Phase 2 Data Presentations at The Liver Meeting Detail SVR12 Rates from Two Studies as Well as SVR8 Rates in Patients for Whom Direct-Acting Antiviral Treatment Previously Failed KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from three Phase 2 clinical trials evaluating MK-3682B (MK-3682/grazoprevir/ruzasvir1), the companys investigational all-oral, triple-combination regimen for the treatment of chronic hepatitis C (HCV) infection (informally referred to as MK3). Language: English Contact: Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986orAmy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
October 14, 2016 October 17, 2016: Volume 3
2016-10-24 19:40:07| PortlandOnline
Public testimony on Comprehensive Plan Early Implementation Package Recommended Draft PDF Document, 16,772kbCategory: Public Testimony on the Recommended Draft
October 7, 2016 October 13, 2016: Volume 3
2016-10-18 19:23:20| PortlandOnline
Public testimony on Comprehensive Plan Early Implementation Package Recommended Draft PDF Document, 19,059kbCategory: Public Testimony on the Recommended Draft
October 1, 2016 October 6, 2016: Volume 3
2016-10-11 20:25:41| PortlandOnline
Public testimony on Comprehensive Plan Early Implementation Package Recommended Draft PDF Document, 18,469kbCategory: Public Testimony on the Recommended Draft
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] next »